Francesca Rampoldi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Francesca Rampoldi has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Abdi Demera
Institute of Immunology, Hannover Medical School, Hannover, Germany 1
1 shared publication - Abel Viejo-Borbolla
Institute of Virology, Hannover Medical School, Hannover, Germany
1 shared publication - Ahmed Hassan
Institute of Immunology, Hannover Medical School, Hannover, Germany
1 shared publication - Anika Janssen
Institute of Immunology, Hannover Medical School 1 , Hannover, Germany
1 shared publication - Ayesha Dhillon-LaBrooy
Institute of Medical Microbiology and Hygiene, University Medical Center of Johannes Gutenberg University, Mainz 55131, Germany
1 shared publication - Beate Weidenthaler-Barth
Johannes Gutenberg University Mainz
1 shared publication
Latest Publications
- 12 October 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (4) , 844-854.e2
Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vγ4+ γδ T Cells
- 12 October 2023
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 144 (4) , 844-854.e2
Inhibition of Mitochondrial Translation Ameliorates Imiquimod-Induced Psoriasis-Like Skin Inflammation by Targeting Vγ4+ γδ T Cells
- Open Access
- 19 July 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (9)
A CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR
The innate and adaptive roles of γδ T cells and their clonal γδ T cell receptors (TCRs) in immune responses are still unclear. Recent studies of γδ TCR repertoire dynamics showed massive expansion of individual Vδ1+ γδ T cell clones during viral infection. To judge whether such expansion is random or actually represents TCR-dependent adaptive immune responses, information about their cognate TCR ligands is required. Here, we used CRISPR/Cas9-mediated screening to identify HLA-DRA, RFXAP, RFX5, and CIITA as required for target cell recognition of a CMV-induced Vγ3Vδ1+ TCR, and further characterization revealed a direct interaction of this Vδ1+ TCR with the MHC II complex HLA-DR. Since MHC II is strongly upregulated by interferon-γ, these results suggest an inflammation-induced MHC-dependent immune response of γδ T cells.
- 19 July 2022
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 219 (9)
Open AccessA CMV-induced adaptive human Vδ1+ γδ T cell clone recognizes HLA-DR
The innate and adaptive roles of γδ T cells and their clonal γδ T cell receptors (TCRs) in immune responses are still unclear. Recent studies of γδ TCR repertoire dynamics showed massive expansion of individual Vδ1+ γδ T cell clones during viral infection. To judge whether such expansion is random or actually represents TCR-dependent adaptive immune responses, information about their cognate TCR ligands is required. Here, we used CRISPR/Cas9-mediated screening to identify HLA-DRA, RFXAP, RFX5, and CIITA as required for target cell recognition of a CMV-induced Vγ3Vδ1+ TCR, and further characterization revealed a direct interaction of this Vδ1+ TCR with the MHC II complex HLA-DR. Since MHC II is strongly upregulated by interferon-γ, these results suggest an inflammation-induced MHC-dependent immune response of γδ T cells.
- Open Access
- 24 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (65) , 109201-109216
Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
- 24 November 2017
- Published by Impact Journals, LLC in Oncotarget
- Vol. 8 (65) , 109201-109216
Open AccessInhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis
Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis Inhibition of hepatocellular carcinoma growth by blockade of glycosphingolipid synthesis